Clinical Trial

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

Study acronym: INTRO
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This research is being done to see if using oral tacrolimus before endoscopy, can prevent pancreatitis that may occur after ERCP (a type of gastrointestinal endoscopy).
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2022-02-14; most recent amendment 2025-12-05.
Status change: Not Yet Recruiting → Recruiting 2023-01-30
Trial Details
NCT Number NCT05252754
Lead Sponsor Johns Hopkins University
Conditions Post-ERCP Acute Pancreatitis
Enrollment 4,874 participants
Start Date 2023-01-18
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-09